Slingsby Brian Taylor
Mineralys Therapeutics, Inc. · Director, 10% Owner
Slingsby Brian Taylor is listed in filings as Director, 10% Owner at Mineralys Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 20, 2026, including sale activity and purchase activity. Recent filings connect the profile to Mineralys Therapeutics, Inc. (MLYS). The current snapshot covers public activity from Jul 26, 2024 to Feb 20, 2026. Reported amounts are shown as $232.9K to $3.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3M259.3k shares | BuyMar 13, 2025 | $13.50 | $26.71 | |
| $7M550k shares | SellJul 24, 2024 | $13.05 | $26.71 |